Thought Leadership | Fish & Richardson

Diversity, Equity & Inclusion

Pro Bono & Social Responsibility

Legal Operations

Legal Project Management

Knowledge Management

Legal Technology Services

Patent Litigation

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Standard Essential Patents

Chancery & Corporate Governance

<p><em>Inter Partes </em>Review</p>

Post-Grant Review

<p><em>Ex Parte</em> Reexamination</p>

Supplemental Examination

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Electrical & Computer Technology

Software & Internet

Consumer Electronics

Artificial Intelligence

Digital Media & E-Commerce

Financial, Business & FinTech Services

Telecommunications

Energy & Chemicals

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Autonomous Vehicles

Thought Leadership

IP Law Essentials

Post-Grant Annual Reports

Search results

Blog | February 08, 2013

EDVA grants motion in limine precluding pre-notice data to be used for determining post-notice price erosion

Event | February 08, 2013

U.S. Patent Law Developments 2009

Event | February 07, 2013

Bio NJ 20th Anniversary Annual Dinner Meeting

Blog | January 30, 2013

SDCA broadly construes comparable licenses and allows profit split/Nash bargaining

News | January 29, 2013

Fish Principal Jonathan E. Singer Named Minnesota Lawyer 2012 "Attorney of Year" and Law360 "2012 MVP"

Blog | January 28, 2013

Preliminary Responses in Inter Partes Review and Post-Grant Review

Blog | January 28, 2013

MDFL takes an expansive view of comparable licenses

Blog | January 25, 2013

NDCA grants new trial based on violation of entire market value rule

Article | January 24, 2013

Personalized Medicine-Slowing Down for "Free Riders"

News | January 23, 2013

Fish Named 2013 "Go-To Intellectual Property Law Firm" for Top Fortune 500 Companies

Blog | January 18, 2013

USPTO handles first case under Covered Business Method review procedure

Event | January 16, 2013

Biotech and Pharmaceutical Patents at the Federal Circuit: 2012 Year in Review